Group 1 - The company is preparing for an H-share issuance and listing, which involves various costs including underwriting fees, legal fees, and other related expenses [1] - The board of directors has been authorized to select professional intermediaries for the issuance, including sponsors, underwriters, and legal advisors [2][3] - The underwriting method will be determined based on market conditions and regulatory approvals [3] Group 2 - The company plans to issue H-shares to eligible investors in Hong Kong and other regions, transitioning to a dual listing on both A-share and H-share markets [7] - The board has proposed that the validity period for the issuance resolution be set at 24 months, extendable if regulatory approvals are obtained within this timeframe [10][29] - The company will use the funds raised for R&D, product expansion, market development, and general corporate purposes, with adjustments allowed based on actual needs [32][33] Group 3 - The company has appointed Ernst & Young as the auditor for the H-share issuance and listing [40] - The board has confirmed the roles of directors post-issuance, including executive and independent directors [43] - The company will apply for registration as a non-Hong Kong company in accordance with Hong Kong regulations [46][47] Group 4 - The company will purchase directors and officers liability insurance and prospectus liability insurance to enhance risk management [52][53] - The company has proposed amendments to its articles of association and related rules to align with the H-share issuance [54][55]